Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries

Vaccine
Ashraf A BasuniW F Carman

Abstract

The prevalence rate of hepatitis B virus (HBV) infection in Pacific Island countries is amongst the highest in the world. Hepatitis B immunisation has been incorporated into national programmes at various times, often with erratic supply and coverage, until a regionally co-ordinated programme, which commenced in 1995 ensured adequate supply. The effectiveness of these programmes was recently evaluated in four countries, Vanuatu and Fiji in Melanesia, Tonga in Polynesia and Kiribati in Micronesia. That evaluation established that the programmes had a substantial beneficial impact in preventing chronic hepatitis B infection [Vaccine 18 (2000) 3059]. Several studies of hepatitis B vaccination programmes in endemic countries have identified the potential significance of surface gene mutants as a cause for failure of immunisation. In the study outlined in this paper, we screened infected children and their mothers for the emergence and prevalence of these variants in specimens collected from the four country evaluation. Although the opportunity for the emergence of HBV vaccine escape mutants in these populations was high due to the presence of a considerable amount of the virus in the population and the selection pressure from vacci...Continue Reading

References

Apr 10, 1975·The New England Journal of Medicine·C E StevensW C Lee
May 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G McMahonL Ostberg
Jan 12, 1991·Lancet·K MoriyamaK Okochi
Aug 11, 1990·Lancet·W F CarmanH C Thomas
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D R MilichA McLachlan
Sep 14, 1989·The New England Journal of Medicine·C A AlperE J Yunis
Sep 1, 1989·Journal of Medical Virology·B R SpeedI D Gust
May 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S D LeeM J Tong
Mar 1, 1985·Journal of Medical Virology·L Y HwangF Deinhardt
Feb 1, 1994·The Journal of General Virology·V D KarthigesuC R Howard
Sep 18, 1996·JAMA : the Journal of the American Medical Association·H L ChenD S Chen
Jan 1, 1996·Journal of Hepatology·A E HawkinsG J Alexander
Dec 11, 1997·The New England Journal of Medicine·W M Lee
Dec 16, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W F CarmanR Sanders
Jan 13, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·U Protzer-KnolleG Gerken
Mar 9, 1999·The Journal of Infectious Diseases·C L ThioD L Thomas
Oct 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H Y HsuH L Chen
Apr 7, 2000·The American Journal of Pathology·F V Chisari
Jun 10, 2000·Journal of Viral Hepatitis·A A BasuniW F Carman

❮ Previous
Next ❯

Citations

Apr 30, 2010·Bulletin of the World Health Organization·C John ClementsJoseph Torresi
Jul 1, 2007·Asian Journal of Transfusion Science·Michael A Purdy
May 3, 2005·Current Opinion in Infectious Diseases·Pier-Angelo TovoAntonia Versace
Nov 10, 2009·Pathologie-biologie·P Pineau, P Tiollais
Sep 7, 2013·Journal of Medical Virology·Michael O BacligFilipinas F Natividad
Feb 7, 2007·Virus Research·Marisol Devesa, Flor H Pujol
Aug 27, 2005·Journal of Medical Virology·Hai-Xia SuYong-Ping Yan
Feb 22, 2007·Journal of Medical Virology·Robert GibbDavid Drummond
Aug 19, 2014·Journal of Gastroenterology and Hepatology·Jessica HowellMargaret Hellard
Jul 14, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Seyed Moayed AlavianSeyed Mohammad Jazayeri
Jun 29, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Meifang HanKathy Jackson
Apr 11, 2020·Wiener medizinische Wochenschrift·Mohammad Reza AghasadeghiAmitis Ramezani
Jun 9, 2015·World Journal of Hepatology·Shan GaoCarla S Coffin
Mar 17, 2016·Population Health Metrics·Karen CarterRichard Taylor
Feb 7, 2020·Hepatology Communications·Shivali S Joshi, Carla S Coffin
Aug 23, 2020·Vaccines·Takako Inoue, Yasuhito Tanaka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.